XGEN Venture

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

$EpilepsyGTx secures £25m Series A from investors to advance gene therapies for refractory epilepsy$ $EpilepsyGTx secures £25m Series A from investors to advance gene therapies for refractory epilepsy$

EpilepsyGTx

10 Dec 2025

EpilepsyGTx secures £25m Series A from investors to advance gene therapies for refractory epilepsy

EpilepsyGTx develops gene therapies for severe epilepsy, aiming to stop seizures with a single targeted treatment rather than long-term medication.

XGEN Venture

- Life Sciences
1(12 months)
xgenventure.com
Update Information

More venture news

Happl
13 May 2026
Happl raises £8m Series A led by Portage Ventures to build global employee benefits operating system for multinational employers
Series AHR
Adfin
12 May 2026
Adfin lands £13m Series A led by Index Ventures for agentic business payments and cash management platform
Series AFintech
Fifth Dimension
12 May 2026
Fifth Dimension lands £19m Series A led by HV Capital to deliver decision intelligence to real-assets investors and managers
Series AProperty

XGEN Venture

Investment Portfolio

EpilepsyGTx secures £25m Series A from investors to advance gene therapies for refractory epilepsy

More venture news

Happl raises £8m Series A led by Portage Ventures to build global employee benefits operating system for multinational employers

Adfin lands £13m Series A led by Index Ventures for agentic business payments and cash management platform

Fifth Dimension lands £19m Series A led by HV Capital to deliver decision intelligence to real-assets investors and managers